Registration Dossier

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study (OECD)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Reference substance name:
Oxalic acid
EC Number:
205-634-3
EC Name:
Oxalic acid
Cas Number:
144-62-7
IUPAC Name:
oxalic acid

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
dimethyl sulphoxide
Concentration:
12.5%, 25% and 50%
No. of animals per dose:
3 test groups of 5 animal (3 different concentrations).

Results and discussion

In vivo (LLNA)

Results
Parameter:
SI
Remarks on result:
other: see Remark
Remarks:
None of the 3 concentrations tested reached the stimulation index of 3: The stimulation index at a concentration of 12.5% was of 2.6 The stimulation index at a concentration of 25% was of 1.9 The stimulation index at a concentration of 50% was of 2.5

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
The EC3 value (derived by linear interpolation) could not be calculated as the
stimulation indices of all concentrations were below 3.
Consequently, according to OECD 429 and the criteria given in Annex I of Regulation (EC) 1272/2008, the test item Oxalic Acid, as described in this report is expected to have no sensitising properties and therefore, should not be regarded as a dermal sensitiser